-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, researchers assessed whether supplemental bovine lactoferrin (bLf) would undermine the acceptance of prevention probiotic administration intestinal tract less than 31 weeks of gestational age preterm children microbiota development, research results have been published in Pediatr Gastroenterol Nutr J
Preventive management
The researchers recruited subjects from the LACUNA trial (ISRCTN66482337) and were randomly assigned to receive daily probiotic supplements or a mixture of probiotics supplemented with 100 mg bLf and milk powder/human milk
The results showed that in the two feeding interventions, the diversity of the infant's microbiota did not increase over time
In summary, the results of this study indicate that bovine lactoferrin supplements have little effect on the microbiota composition/function of premature infants receiving probiotics, and therefore, it is unlikely to disrupt the development of the microbiota
Original source:
Kelly Grzywacz, et al.
Bovine Lactoferrin Supplementation Does Not Disrupt Microbiota Development in Preterm Infants Receiving Probiotics
in this message